Recurrent Non-small Cell Lung Cancer Terminated Phase 2 Trials for Crizotinib (DB08865)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated2 IdentifierTitlePurposeDrugs
NCT02134912S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After CrizotinibTreatment